Showing results (1-10 of 34) with videos related to
Sort By:
Pageof 4
Circulation Research|January 22, 2011
Vascular calcification in chronic renal failure: what have we learned from animal studies?Ellen Neven, Patrick C D'HaeseCardiorenal Medicine|July 25, 2017
Characterization of an Animal Model to Study Risk Factors and New Therapies for the Cardiorenal Syndrome, a Major Health Issue in Our Aging PopulationAnja Verhulst, Ellen Neven, Patrick C D'HaeseInternational Journal of Molecular Sciences|December 26, 2018
Metformin: A Candidate Drug for Renal DiseasesRaphaëlle Corremans, Benjamin A Vervaet, Patrick C D'Haese, et al.International Journal of Molecular Sciences|October 20, 2020
Extracellular Nucleotides Regulate Arterial Calcification by Activating Both Independent and Dependent Purinergic Receptor Signaling PathwaysBritt Opdebeeck, Isabel R Orriss, Ellen Neven, et al.Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|January 17, 2022
Sclerostin Protects Against Vascular Calcification Development in MiceAnnelies De Maré, Britt Opdebeeck, Ellen Neven, et al.Kidney International|March 18, 2011
Cell biological and physicochemical aspects of arterial calcificationEllen Neven, Tineke M De Schutter, Marc E De Broe, et al.Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 18, 2011
Iron and vascular calcification. Is there a link?Ellen Neven, Tineke M De Schutter, Geert J Behets, et al.Pharmaceutics|August 28, 2021
Chronic Kidney Disease-Induced Arterial Media Calcification in Rats Prevented by Tissue Non-Specific Alkaline Phosphatase Substrate Supplementation Rather Than Inhibition of the EnzymeBritt Opdebeeck, Ellen Neven, José Luis Millán, et al.Bone|May 4, 2020
Pharmacological TNAP inhibition efficiently inhibits arterial media calcification in a warfarin rat model but deserves careful consideration of potential physiological bone formation/mineralization impairmentBritt Opdebeeck, Ellen Neven, José Luis Millán, et al.Pediatric Nephrology (Berlin, Germany)|March 5, 2015
From skeletal to cardiovascular disease in 12 steps-the evolution of sclerostin as a major player in CKD-MBDVincent M Brandenburg, Patrick D'Haese, Annika Deck, et al.Pageof 4